Legend Biotech (LEGN) Long-Term Deferred Tax (2019 - 2021)

Legend Biotech (LEGN) has 3 years of Long-Term Deferred Tax data on file, last reported at $22.8 million in Q4 2021.

• Quarterly Long-Term Deferred Tax fell 25.98% year-over-year to $22.8 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $22.8 million (down 25.98% YoY) and the FY2021 annual result came in at $22.8 million, down 25.98% from the prior year.
• Long-Term Deferred Tax eased to $22.8 million in Q4 2021, from $30.8 million in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $30.8 million in Q4 2020 to a low of $5.7 million in Q4 2019.
• A 3-year average of $19.8 million and a median of $22.8 million in 2021 frame the typical range for Long-Term Deferred Tax.
• Annual changes were most pronounced in 2020 — Long-Term Deferred Tax jumped 438.86% — and 2021, when it fell 25.98%.
• Tracing LEGN's Long-Term Deferred Tax over 3 years: stood at $5.7 million in 2019, then jumped by 438.86% to $30.8 million in 2020, then slipped by 25.98% to $22.8 million in 2021.
• The last three Long-Term Deferred Tax figures came in at $22.8 million (Q4 2021), $30.8 million (Q4 2020), and $5.7 million (Q4 2019), per Business Quant data.